Delayed Swiss Exchange  -  05/23 11:30:55 am EDT
65.80 CHF   -1.79%
04/28CPH CHEMIE + PAPIER : ZKB Roadshow presentation, 28. April 2022 (pdf, 1.8 mb)
04/28CPH CHEMIE + PAPIER : ZKB Roadshow Präsentation, 28. April 2022 in Englisch (pdf, 1.8 mb)
03/21CPH CHEMIE + PAPIER HOLDING AG : Ex-dividend day for final dividend
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

2021 first-half results: Chemistry and Packaging on track; earnings for Paper depressed by higher raw materials costs

07/21/2021 | 01:03am EDT

Perlen, 21 July 2021 - The restrictions imposed in response to the coronavirus pandemic were gradually eased in many countries in the first half of 2021, and economies showed some signs of recovery. The higher demand helped raise the CPH Group's net sales for the period to CHF 243.7 million - an increase of 5.1%, or of 5.7% excluding currency factors.

Chemistry posts highly favourable earnings

The Chemistry Division benefited from its customers' action backlogs and saw high order volumes for various product lines, especially for the molecular sieves used in oxygen concentration. 'With its innovative products, our Chemistry Division has earned itself a leading market position,' says Group CEO Peter Schildknecht. 'It substantially increased its first-half net sales, and achieved an even stronger improvement in its first-half earnings result.'

Paper feels the effects of greater predatory competition

The Paper Division sold higher volumes of its products than it had in the first half of 2020, when its machines had stood idle for lengthy periods as a result of the coronavirus pandemic. But with paper prices simultaneously declining as a result of increasing industry overcapacities, its first-half net sales were below their 2020 levels, despite the higher sales volumes.

Packaging achieves growth in Latin America and Asia

First-half developments in the Packaging Division were a mixed affair. On the one hand, demand for its products was lower in western countries, where pharmaceuticals manufacturers had built up their stocks in 2020 and were more restrained in their new order placements. At the same time, the extensive mask-wearing requirements prompted declines in the prevalence of other viral infections such as colds and influenza, which in turn substantially reduced the sales volumes of over-the-counter self-medication products. Both these trends were more than offset, however, through double-digit percentage net sales growth in Latin America and Asia.

Steep rises in raw materials costs

The increase in demand - steep in some cases - led to delivery shortages of certain raw materials and massive hikes in their prices. Many of the plastics used in the Packaging Division were in short supply, and their prices rose dramatically. The cost increases could only be passed on to the markets with some delay, and margins were pressured accordingly. Recovered paper is the key raw material for the Paper Division. But the declines in the production volumes of graphic printing paper during the pandemic reduced the amounts of waste paper collected. The resulting lower recovered paper volumes coincided in spring with a pick-up in demand for newsprint and magazine paper. The situation was exacerbated by a high demand for the mixed paper used by the cardboard industry in packagings for the booming online sales segment. Recovered paper prices rose accordingly, and first-half earnings for the Paper Division were negative as expected.

Group earnings before interest and taxes (EBIT) for the first-half period declined 67.8% to CHF 5.7 million. The net result amounted to CHF 5.9 million, which was still around one-third of its prior-year level (excluding prior-year extraordinary income of CHF 12.0 million).

Cash flow for the first-half period decreased accordingly, declining 43.8% to CHF 15.4 million. With a balance sheet equity ratio of 65%, the CPH Group remains in sound financial health, with liquid funds of CHF 113.2 million.

A pioneering COVID testing and vaccination role

To protect its many employees who are involved in production at its various sites and are thus unable to work temporarily from home, the CPH Group has developed and consistently applies hygiene and protection concepts to prevent coronavirus infection. At the Group's Perlen site, several hundred employees participated in a pilot scheme by Canton Lucerne in spring under which weekly mass COVID testing was conducted throughout the operation. The Perlen operation played a further pioneering role in June by offering its employees on-site COVID vaccinations.

A cautious full-year outlook

'Should the coronavirus pandemic be effectively contained through the current vaccination programmes, economies are likely to show further positive developments in the rest of 2021 in many parts of the world,' says Peter Schildknecht. 'So we are confident of reporting higher net sales for the year for the CPH Group.' On the expenditure side, high raw materials costs (especially for recovered paper) must continue to be expected, and can only be partially passed on to the markets concerned. As already announced in February, the Group's full-year EBIT for 2021 will be substantially below its 2020 level. Based on current knowledge, however, the CPH Group still expects to report a marginally positive net result for the year.

CPH Chemie + Papier Holding AG contacts

Dr. Peter Schildknecht, CEO, +41 41 455 8757

Richard Unterhuber, CFO, +41 41 455 8753, investor.relations@cph.ch

Christian Weber, Head of Corporate Communications, +41 41 455 8751, medien@cph.ch

Download media release (pdf, 148kb)

Half-Year Report 2021 (pdf, 65kb)


CPH Chemie + Papier Holding AG published this content on 21 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 July 2021 05:02:03 UTC.

© Publicnow 2021
04/28CPH CHEMIE + PAPIER : ZKB Roadshow presentation, 28. April 2022 (pdf, 1.8 mb)
04/28CPH CHEMIE + PAPIER : ZKB Roadshow Präsentation, 28. April 2022 in Englisch (pdf, 1.8 mb)
03/21CPH CHEMIE + PAPIER HOLDING AG : Ex-dividend day for final dividend
03/17CPH CHEMIE + PAPIER : presentation, AGM, 17. March 2022, (pdf in German, 3.4 mb)
03/02CPH CHEMIE + PAPIER : FY2021 Results update (pdf, 369kb)
02/23CPH Chemie + Papier Holding AG Reports Earnings Results for the Full Year Ended Decembe..
02/22CPH CHEMIE + PAPIER : General business report 2021
02/22CPH CHEMIE + PAPIER : Business report Chemistry 2021
02/22CPH CHEMIE + PAPIER : presentation, Annual results 2021, 22 February 2022 (pdf, 1.6mb)
02/22CPH Chemie + Papier Tumbles to FY21 Loss on One-time Impairment
More news
Sales 2022 568 M 588 M 588 M
Net income 2022 43,5 M 45,1 M 45,1 M
Net cash 2022 17,4 M 18,0 M 18,0 M
P/E ratio 2022 9,40x
Yield 2022 2,81%
Capitalization 395 M 409 M 409 M
EV / Sales 2022 0,66x
EV / Sales 2023 0,67x
Nbr of Employees 1 104
Free-Float 62,1%
Duration : Period :
CPH Chemie + Papier Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CPH CHEMIE + PAPIER HOLDING AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 3
Last Close Price 65,80 CHF
Average target price 93,43 CHF
Spread / Average Target 42,0%
EPS Revisions
Managers and Directors
Peter Schildknecht Group Chief Executive Officer
Gerold Brütsch Chief Financial Officer
Peter Schaub Chairman
Tamer Talaat Deputy Chairman
Christian Wipf Director
Sector and Competitors
1st jan.Capi. (M$)
UPM-KYMMENE OYJ-3.56%18 156
STORA ENSO OYJ10.25%14 889
SUZANO S.A.-14.57%14 233
HOLMEN AB (PUBL)18.47%8 402